Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

A practical AI model for endoscopic diagnosis of gastric premalignant lesions and its application to predicting metachronous recurrence.

Created on 17 Oct 2026

Authors

Jinju Choi, Cheol Min Shin, Jinbae Park, Gyuseon Song, Jaeyoung Lee, Hae Dong Lee, Yong Hoon Choi, Soo-Jeong Cho, Seung Joo Kang, Young Soo Park, Nayoung Kim

Published in

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. Oct 16, 2026. Epub Oct 16, 2026.

Abstract

To evaluate the diagnostic performance of an artificial intelligence (AI)-based optical system for chronic atrophic gastritis (CAG) and intestinal metaplasia (IM), and its ability to predict metachronous recurrence.
We analyzed 72,794 endoscopic images from 5,000 patients undergoing esophagogastroduodenoscopy with biopsy-confirmed CAG/IM. A convolutional neural network model was developed and compared with experts (n=16) and novices (n=15). The association between AI-predicted IM extent and metachronous recurrence after endoscopic resection of early gastric cancer (n=458) was evaluated using Cox regression.
For CAG, the AI model achieved accuracies of 0.819 (antrum) and 0.864 (body), with corresponding AUCs of 0.885 and 0.901. For IM, accuracies were 0.759 and 0.723, with AUCs of 0.835 and 0.744. The AI model outperformed novices and experts in CAG diagnosis (accuracy: 0.855 vs. 0.705 and 0.751) and outperformed novices in IM diagnosis (0.875 vs. 0.781). Although individual HRs for AI-predicted IM extent were not statistically significant (2.11 [95% CI, 0.25-17.67], antral IM only; 4.27 [0.57-31.97], IM extending to body), a significant dose-response relationship with recurrence risk was observed (Ptrend=0.043).
This AI model showed clinically acceptable performance and potential usefulness for CAG/IM diagnosis in a single-center study but requires multicenter external validation before clinical adoption.

PMID:
42888072
Bibliographic data and abstract were imported from PubMed on 17 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement